Trials / Completed
CompletedNCT01966055
Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
A Phase 1, Open-label, Multi-center Study to Determine the PK and Safety of Solithromycin as Add-on Therapy in Adolescents With Suspected or Confirmed Bacterial Infection
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Melinta Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
A study of the safety and pharmacokinetics of solithromycin capsules in adolescents
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solithromycin |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-08-01
- Completion
- 2014-09-01
- First posted
- 2013-10-21
- Last updated
- 2017-02-23
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01966055. Inclusion in this directory is not an endorsement.